Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of PTPRZ1 mRNA | decreases expression | 19933214
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PTPRZ1 mRNA | affects expression | 16483693
|
D003035 |
Cobalt |
[tungsten carbide binds to Cobalt] which results in decreased expression of PTPRZ1 mRNA | affects binding|decreases expression | 20105288
|
C018021 |
cobaltous chloride |
cobaltous chloride results in decreased expression of PTPRZ1 mRNA | decreases expression | 20105288
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of PTPRZ1 mRNA | decreases expression | 16002434
|
C020326 |
ferric nitrilotriacetate |
ferric nitrilotriacetate results in increased expression of PTPRZ1 mRNA | increases expression | 18055543
|
C020326 |
ferric nitrilotriacetate |
ferric nitrilotriacetate results in increased expression of PTPRZ1 protein | increases expression | 18055543
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in increased expression of PTPRZ1 mRNA | increases expression | 20024957
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PTPRZ1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PTPRZ1 mRNA | increases expression | 12832660
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PTPRZ1 mRNA | increases expression | 19465110
|
C002802 |
tungsten carbide |
[tungsten carbide binds to Cobalt] which results in decreased expression of PTPRZ1 mRNA | affects binding|decreases expression | 20105288
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.71 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.71 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.35 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.35 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.08 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cobalt |
2.08 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
ferric nitrilotriacetate |
4.44 | 8340253 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.66 | 11237771 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
4.04 | 19716837 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.95 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 8697196 16354765 15340226 15668235 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
4.24 | 16823706 15059100 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.11 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.11 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.13 | 15138306 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.93 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.16 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
MESH:D016481 |
Helicobacter Infections |
marker/mechanism |
|
| |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.99 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.99 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 16959395 18606429 16354765 8697196 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cobalt |
5.80 | 17039479 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.80 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
ferric nitrilotriacetate |
4.35 | 18617210 15834431 |
MESH:D007680 |
Kidney Neoplasms |
|
ferric nitrilotriacetate |
4.80 | 9667754 18055543 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.18 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.18 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.44 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.20 | 12151625 |
MESH:D008173 |
Lung Diseases, Obstructive |
|
Cobalt |
6.08 | 6434250 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.02 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11896295 11118676 11399792 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.02 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.51 | 16289102 18247401 16644109 12479363 15754350 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cobalt |
4.05 | 6434250 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.41 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 16192470 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
3.50 | 20375083 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |